GALM is the cytosolic aldose 1-epimerase (galactose mutarotase; EC 5.1.3.3) that catalyzes the first step of the Leloir pathway of galactose metabolism. It interconverts the beta- and alpha-anomers of D-galactose (beta-D-galactose <=> alpha-D-galactose), maintaining the anomeric equilibrium and ensuring a sufficient supply of the alpha-anomer, which galactokinase (GALK1) requires as its substrate; the downstream Leloir enzymes GALK1, GALT, and GALE then convert galactose into glucose 1-phosphate. GALM also mutarotates D-glucose (alpha-D-glucose <=> beta-D-glucose), though it prefers galactose over glucose. The enzyme is a monomer with a single-domain beta-sandwich fold typical of the aldose epimerase family; catalysis uses His-176 as the proton donor and Glu-307 as the proton acceptor, with His-107 also contributing. Biallelic loss-of-function GALM variants cause galactose mutarotase deficiency (galactosemia type IV, GALAC4), an autosomal recessive inborn error of galactose metabolism.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0033499
beta-D-galactose catabolic process via UDP-galactose, Leloir pathway
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic (IBA) inference that GALM participates in the Leloir pathway of galactose catabolism. This is the core biological process of GALM: it catalyzes the first (mutarotase) step supplying alpha-D-galactose to GALK1.
Reason: Consistent with the experimentally established Leloir-pathway role and the PANTHER aldose-1-epimerase family. Represents a core function.
|
|
GO:0004034
aldose 1-epimerase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic (IBA) inference of aldose 1-epimerase activity, the core molecular function of GALM, matching the family-level assignment for PTN000009552.
Reason: The defining catalytic activity of GALM, independently supported by direct experimental characterization (PMID:12753898). Core molecular function.
|
|
GO:0006006
glucose metabolic process
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: Phylogenetic inference that GALM participates in glucose metabolism, reflecting the family's ability to mutarotate glucose in addition to galactose.
Reason: GALM does mutarotate D-glucose in vitro, but with lower affinity/turnover than galactose (KM 54 mM vs 37 mM; kcat 4900 vs 12000 s-1), and the enzyme "exhibits a preference for galactose over glucose" (PMID:12753898). Glucose mutarotation is a genuine but secondary activity, not the core physiological role.
Supporting Evidence:
PMID:12753898
the protein has aldose 1-epimerase activity and exhibits a preference for galactose over glucose
|
|
GO:0004034
aldose 1-epimerase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Automated (RHEA/EC 5.1.3.3) assignment of aldose 1-epimerase activity, the core molecular function.
Reason: Correctly mapped from EC 5.1.3.3 / RHEA:10264,RHEA:28675 to the specific MF term; matches experimental evidence.
|
|
GO:0005737
cytoplasm
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: Subcellular-location mapping (UniProt SL-0086) placing GALM in the cytoplasm.
Reason: Consistent with the UniProt subcellular location (Cytoplasm) and the Reactome cytosol annotation. Broader than cytosol but not incorrect.
|
|
GO:0005975
carbohydrate metabolic process
|
IEA
GO_REF:0000002 |
KEEP AS NON CORE |
Summary: InterPro2GO mapping to the high-level carbohydrate metabolic process, from the aldose epimerase domains.
Reason: True but a very general grouping term. The specific galactose/hexose processes below are more informative; retained as a non-core parent.
|
|
GO:0016853
isomerase activity
|
IEA
GO_REF:0000002 |
MODIFY |
Summary: InterPro2GO mapping to the generic parent term isomerase activity.
Reason: Correct but overly general: GALM's activity is specifically aldose 1-epimerase activity (GO:0004034), which is a descendant of isomerase activity and is already annotated with strong experimental support. Replace the generic parent with the specific MF.
Proposed replacements:
aldose 1-epimerase activity
|
|
GO:0019318
hexose metabolic process
|
IEA
GO_REF:0000120 |
KEEP AS NON CORE |
Summary: Automated mapping (UniPathway/InterPro) to hexose metabolic process, consistent with GALM acting on the hexoses galactose and glucose.
Reason: Accurate parent term encompassing galactose and glucose metabolism, but less specific than the galactose process terms. Retained as a non-core grouping term.
|
|
GO:0030246
carbohydrate binding
|
IEA
GO_REF:0000002 |
MARK AS OVER ANNOTATED |
Summary: InterPro2GO mapping to carbohydrate binding, derived from the sugar-binding beta-sandwich (GH-type carbohydrate-binding) domain signatures.
Reason: GALM binds galactose/glucose only transiently as catalytic substrates in its active site, not as a lectin-type carbohydrate-binding module. GO:0030246 (carbohydrate binding) implies a dedicated binding function distinct from catalysis; this is an over-annotation propagated from the structural fold signature. The catalytic substrate interaction is already captured by the aldose 1-epimerase activity annotation.
|
|
GO:0033499
beta-D-galactose catabolic process via UDP-galactose, Leloir pathway
|
TAS
Reactome:R-HSA-70370 |
ACCEPT |
Summary: Reactome-curated (TAS) assignment of GALM to the Leloir pathway of galactose catabolism.
Reason: Curator-asserted pathway membership matching the established biology; core biological process.
|
|
GO:0006012
galactose metabolic process
|
IEA
GO_REF:0000041 |
ACCEPT |
Summary: UniPathway-based (UPA00214) mapping to galactose metabolic process.
Reason: Core biological process of GALM; the anomer interconversion it catalyzes initiates galactose metabolism. Independently supported by IDA (PMID:12753898).
|
|
GO:0004034
aldose 1-epimerase activity
|
EXP
PMID:12753898 Identification and characterisation of human aldose 1-epimer... |
ACCEPT |
Summary: Experimental demonstration that recombinant human GALM has aldose 1-epimerase activity, with confirmed catalytic residues.
Reason: Core molecular function, directly demonstrated by enzyme assays on purified recombinant protein plus site-directed mutagenesis of catalytic residues.
Supporting Evidence:
PMID:12753898
Enzyme assays show that the protein has aldose 1-epimerase activity and exhibits a preference for galactose over glucose. Site-directed mutagenesis confirmed the involvement of three residues involved in catalysis and substrate binding.
|
|
GO:0004034
aldose 1-epimerase activity
|
TAS
Reactome:R-HSA-9931926 |
ACCEPT |
Summary: Reactome-curated (TAS) assertion of aldose 1-epimerase activity (in the context of the defective-GALM reaction).
Reason: Core molecular function; consistent with all other MF evidence.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-9931853 |
ACCEPT |
Summary: Reactome-curated (TAS) localization of GALM (the "GALM converts beta-D-GAL to alpha-D-GAL" reaction) to the cytosol.
Reason: Consistent with the cytoplasmic Leloir pathway; the most specific and appropriate location term for GALM. Core localization.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-9931926 |
ACCEPT |
Summary: Reactome-curated (TAS) cytosol localization (defective-GALM reaction context). Duplicate of the preceding cytosol annotation from a related Reactome reaction.
Reason: Correct core localization; duplicate assertion of cytosol is acceptable.
|
|
GO:0004034
aldose 1-epimerase activity
|
IDA
PMID:30451973 Biallelic GALM pathogenic variants cause a novel type of gal... |
ACCEPT |
Summary: Direct assay (IDA) of aldose 1-epimerase activity in the study that identified GALM deficiency as a novel galactosemia; patient/variant proteins showed altered activity.
Reason: Core molecular function, independently confirmed in the disease-gene study.
|
|
GO:0004034
aldose 1-epimerase activity
|
IMP
PMID:30451973 Biallelic GALM pathogenic variants cause a novel type of gal... |
ACCEPT |
Summary: Mutant-phenotype (IMP) evidence that pathogenic GALM variants reduce aldose 1-epimerase activity, linking loss of this MF to disease.
Reason: Loss-of-function variants causing galactosemia type IV support the physiological relevance of this core molecular function.
|
|
GO:0033499
beta-D-galactose catabolic process via UDP-galactose, Leloir pathway
|
IMP
PMID:30451973 Biallelic GALM pathogenic variants cause a novel type of gal... |
ACCEPT |
Summary: Mutant-phenotype (IMP) evidence that GALM loss disrupts the Leloir pathway of galactose catabolism, causing galactose accumulation / galactosemia type IV.
Reason: Biallelic GALM variants cause a novel type of galactosemia by impairing the Leloir pathway; core biological process supported by human disease genetics.
|
|
GO:0033499
beta-D-galactose catabolic process via UDP-galactose, Leloir pathway
|
IDA
PMID:30451973 Biallelic GALM pathogenic variants cause a novel type of gal... |
ACCEPT |
Summary: Direct-assay (IDA) evidence supporting GALM's participation in the Leloir galactose catabolic pathway.
Reason: Core biological process, directly supported. Duplicate of the IBA/TAS Leloir-pathway annotations with independent experimental backing.
|
|
GO:0004034
aldose 1-epimerase activity
|
IDA
PMID:12753898 Identification and characterisation of human aldose 1-epimer... |
ACCEPT |
Summary: Direct assay (IDA) of aldose 1-epimerase activity on purified recombinant human GALM.
Reason: Core molecular function; the foundational biochemical characterization of the enzyme.
Supporting Evidence:
PMID:12753898
Enzyme assays show that the protein has aldose 1-epimerase activity and exhibits a preference for galactose over glucose.
|
|
GO:0005975
carbohydrate metabolic process
|
IDA
PMID:12753898 Identification and characterisation of human aldose 1-epimer... |
KEEP AS NON CORE |
Summary: Direct-assay evidence placing GALM in carbohydrate metabolism (mutarotation of hexose sugars), a high-level grouping process.
Reason: Correct but very general; the specific galactose/glucose metabolic process terms are more informative. Retained as a non-core parent. GALM is described as "a key enzyme of carbohydrate metabolism" (PMID:12753898).
Supporting Evidence:
PMID:12753898
Aldose 1-epimerase or mutarotase (EC 5.1.3.3) is a key enzyme of carbohydrate metabolism catalysing the interconversion of the alpha- and beta-anomers of hexose sugars such as glucose and galactose.
|
|
GO:0042803
protein homodimerization activity
|
IDA
NOT
PMID:12753898 Identification and characterisation of human aldose 1-epimer... |
ACCEPT |
Summary: Negated (NOT) annotation: GALM does not have protein homodimerization activity. Biochemical and structural characterization established that GALM is a monomer.
Reason: The NOT annotation correctly records that GALM does not homodimerize. UniProt reports the SUBUNIT as Monomer (from PMID:12753898 and PMID:15026423). Retaining the negation is informative and consistent with the monomeric solution and crystal state.
|
|
GO:0070062
extracellular exosome
|
HDA
PMID:19056867 Large-scale proteomics and phosphoproteomics of urinary exos... |
KEEP AS NON CORE |
Summary: High-throughput mass-spectrometry (HDA) detection of GALM among proteins recovered from human urinary exosomes.
Reason: Reflects broad proteomic detection in secreted exosomes rather than the enzyme's site of catalytic function, which is the cytosol. Kept as a non-core localization; not part of the core Leloir-pathway function.
Supporting Evidence:
PMID:19056867
we used LC-MS/MS to profile the proteome of human urinary exosomes. Overall, the analysis identified 1132 proteins unambiguously
|
|
GO:0006006
glucose metabolic process
|
IDA
PMID:12753898 Identification and characterisation of human aldose 1-epimer... |
KEEP AS NON CORE |
Summary: Direct-assay evidence that GALM mutarotates D-glucose, participating in glucose metabolism.
Reason: GALM does interconvert glucose anomers, but with lower efficiency than galactose and a demonstrated preference for galactose (PMID:12753898). A real but secondary activity, not the core physiological role.
Supporting Evidence:
PMID:12753898
catalysing the interconversion of the alpha- and beta-anomers of hexose sugars such as glucose and galactose
|
|
GO:0006012
galactose metabolic process
|
IDA
PMID:12753898 Identification and characterisation of human aldose 1-epimer... |
ACCEPT |
Summary: Direct-assay evidence that GALM participates in galactose metabolism via mutarotation of galactose anomers.
Reason: Core biological process; directly demonstrated and consistent with the enzyme's preference for galactose. Foundational to the Leloir pathway.
Supporting Evidence:
PMID:12753898
catalysing the interconversion of the alpha- and beta-anomers of hexose sugars such as glucose and galactose
|
UniProtKB: Q96C23; HGNC:24063; EC 5.1.3.3; 342 aa; PDB 1SNZ/1SO0.
Cached pubs (PMID_12753898, PMID_30451973, PMID_19056867) are all abstract-only (full_text_available: false).
Do not REMOVE experimental annotations on the basis of abstract-only text.
id: Q96C23
gene_symbol: GALM
product_type: PROTEIN
status: IN_PROGRESS
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
GALM is the cytosolic aldose 1-epimerase (galactose mutarotase; EC 5.1.3.3) that
catalyzes the first step of the Leloir pathway of galactose metabolism. It interconverts
the beta- and alpha-anomers of D-galactose (beta-D-galactose <=> alpha-D-galactose),
maintaining the anomeric equilibrium and ensuring a sufficient supply of the alpha-anomer,
which galactokinase (GALK1) requires as its substrate; the downstream Leloir enzymes GALK1,
GALT, and GALE then convert galactose into glucose 1-phosphate. GALM also mutarotates
D-glucose (alpha-D-glucose <=> beta-D-glucose), though it prefers galactose over glucose.
The enzyme is a monomer with a single-domain beta-sandwich fold typical of the aldose
epimerase family; catalysis uses His-176 as the proton donor and Glu-307 as the proton
acceptor, with His-107 also contributing. Biallelic loss-of-function GALM variants cause
galactose mutarotase deficiency (galactosemia type IV, GALAC4), an autosomal recessive
inborn error of galactose metabolism.
existing_annotations:
- term:
id: GO:0033499
label: beta-D-galactose catabolic process via UDP-galactose, Leloir pathway
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
Phylogenetic (IBA) inference that GALM participates in the Leloir pathway of galactose
catabolism. This is the core biological process of GALM: it catalyzes the first (mutarotase)
step supplying alpha-D-galactose to GALK1.
action: ACCEPT
reason: >-
Consistent with the experimentally established Leloir-pathway role and the PANTHER
aldose-1-epimerase family. Represents a core function.
- term:
id: GO:0004034
label: aldose 1-epimerase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: >-
Phylogenetic (IBA) inference of aldose 1-epimerase activity, the core molecular function
of GALM, matching the family-level assignment for PTN000009552.
action: ACCEPT
reason: >-
The defining catalytic activity of GALM, independently supported by direct experimental
characterization (PMID:12753898). Core molecular function.
- term:
id: GO:0006006
label: glucose metabolic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
Phylogenetic inference that GALM participates in glucose metabolism, reflecting the
family's ability to mutarotate glucose in addition to galactose.
action: KEEP_AS_NON_CORE
reason: >-
GALM does mutarotate D-glucose in vitro, but with lower affinity/turnover than galactose
(KM 54 mM vs 37 mM; kcat 4900 vs 12000 s-1), and the enzyme "exhibits a preference for
galactose over glucose" (PMID:12753898). Glucose mutarotation is a genuine but secondary
activity, not the core physiological role.
supported_by:
- reference_id: PMID:12753898
supporting_text: "the protein has aldose 1-epimerase activity and exhibits a preference for galactose over glucose"
- term:
id: GO:0004034
label: aldose 1-epimerase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Automated (RHEA/EC 5.1.3.3) assignment of aldose 1-epimerase activity, the core molecular
function.
action: ACCEPT
reason: >-
Correctly mapped from EC 5.1.3.3 / RHEA:10264,RHEA:28675 to the specific MF term; matches
experimental evidence.
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: >-
Subcellular-location mapping (UniProt SL-0086) placing GALM in the cytoplasm.
action: ACCEPT
reason: >-
Consistent with the UniProt subcellular location (Cytoplasm) and the Reactome cytosol
annotation. Broader than cytosol but not incorrect.
- term:
id: GO:0005975
label: carbohydrate metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: involved_in
review:
summary: >-
InterPro2GO mapping to the high-level carbohydrate metabolic process, from the aldose
epimerase domains.
action: KEEP_AS_NON_CORE
reason: >-
True but a very general grouping term. The specific galactose/hexose processes below are
more informative; retained as a non-core parent.
- term:
id: GO:0016853
label: isomerase activity
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: >-
InterPro2GO mapping to the generic parent term isomerase activity.
action: MODIFY
reason: >-
Correct but overly general: GALM's activity is specifically aldose 1-epimerase activity
(GO:0004034), which is a descendant of isomerase activity and is already annotated with
strong experimental support. Replace the generic parent with the specific MF.
proposed_replacement_terms:
- id: GO:0004034
label: aldose 1-epimerase activity
- term:
id: GO:0019318
label: hexose metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: involved_in
review:
summary: >-
Automated mapping (UniPathway/InterPro) to hexose metabolic process, consistent with GALM
acting on the hexoses galactose and glucose.
action: KEEP_AS_NON_CORE
reason: >-
Accurate parent term encompassing galactose and glucose metabolism, but less specific than
the galactose process terms. Retained as a non-core grouping term.
- term:
id: GO:0030246
label: carbohydrate binding
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: >-
InterPro2GO mapping to carbohydrate binding, derived from the sugar-binding beta-sandwich
(GH-type carbohydrate-binding) domain signatures.
action: MARK_AS_OVER_ANNOTATED
reason: >-
GALM binds galactose/glucose only transiently as catalytic substrates in its active site,
not as a lectin-type carbohydrate-binding module. GO:0030246 (carbohydrate binding) implies
a dedicated binding function distinct from catalysis; this is an over-annotation propagated
from the structural fold signature. The catalytic substrate interaction is already captured
by the aldose 1-epimerase activity annotation.
- term:
id: GO:0033499
label: beta-D-galactose catabolic process via UDP-galactose, Leloir pathway
evidence_type: TAS
original_reference_id: Reactome:R-HSA-70370
qualifier: involved_in
review:
summary: >-
Reactome-curated (TAS) assignment of GALM to the Leloir pathway of galactose catabolism.
action: ACCEPT
reason: >-
Curator-asserted pathway membership matching the established biology; core biological process.
- term:
id: GO:0006012
label: galactose metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000041
qualifier: involved_in
review:
summary: >-
UniPathway-based (UPA00214) mapping to galactose metabolic process.
action: ACCEPT
reason: >-
Core biological process of GALM; the anomer interconversion it catalyzes initiates galactose
metabolism. Independently supported by IDA (PMID:12753898).
- term:
id: GO:0004034
label: aldose 1-epimerase activity
evidence_type: EXP
original_reference_id: PMID:12753898
qualifier: enables
review:
summary: >-
Experimental demonstration that recombinant human GALM has aldose 1-epimerase activity,
with confirmed catalytic residues.
action: ACCEPT
reason: >-
Core molecular function, directly demonstrated by enzyme assays on purified recombinant
protein plus site-directed mutagenesis of catalytic residues.
supported_by:
- reference_id: PMID:12753898
supporting_text: "Enzyme assays show that the protein has aldose 1-epimerase activity and exhibits a preference for galactose over glucose. Site-directed mutagenesis confirmed the involvement of three residues involved in catalysis and substrate binding."
- term:
id: GO:0004034
label: aldose 1-epimerase activity
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9931926
qualifier: enables
review:
summary: >-
Reactome-curated (TAS) assertion of aldose 1-epimerase activity (in the context of the
defective-GALM reaction).
action: ACCEPT
reason: >-
Core molecular function; consistent with all other MF evidence.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9931853
qualifier: located_in
review:
summary: >-
Reactome-curated (TAS) localization of GALM (the "GALM converts beta-D-GAL to alpha-D-GAL"
reaction) to the cytosol.
action: ACCEPT
reason: >-
Consistent with the cytoplasmic Leloir pathway; the most specific and appropriate location
term for GALM. Core localization.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9931926
qualifier: located_in
review:
summary: >-
Reactome-curated (TAS) cytosol localization (defective-GALM reaction context). Duplicate of
the preceding cytosol annotation from a related Reactome reaction.
action: ACCEPT
reason: >-
Correct core localization; duplicate assertion of cytosol is acceptable.
- term:
id: GO:0004034
label: aldose 1-epimerase activity
evidence_type: IDA
original_reference_id: PMID:30451973
qualifier: enables
review:
summary: >-
Direct assay (IDA) of aldose 1-epimerase activity in the study that identified GALM
deficiency as a novel galactosemia; patient/variant proteins showed altered activity.
action: ACCEPT
reason: >-
Core molecular function, independently confirmed in the disease-gene study.
- term:
id: GO:0004034
label: aldose 1-epimerase activity
evidence_type: IMP
original_reference_id: PMID:30451973
qualifier: enables
review:
summary: >-
Mutant-phenotype (IMP) evidence that pathogenic GALM variants reduce aldose 1-epimerase
activity, linking loss of this MF to disease.
action: ACCEPT
reason: >-
Loss-of-function variants causing galactosemia type IV support the physiological relevance
of this core molecular function.
- term:
id: GO:0033499
label: beta-D-galactose catabolic process via UDP-galactose, Leloir pathway
evidence_type: IMP
original_reference_id: PMID:30451973
qualifier: acts_upstream_of_or_within
review:
summary: >-
Mutant-phenotype (IMP) evidence that GALM loss disrupts the Leloir pathway of galactose
catabolism, causing galactose accumulation / galactosemia type IV.
action: ACCEPT
reason: >-
Biallelic GALM variants cause a novel type of galactosemia by impairing the Leloir pathway;
core biological process supported by human disease genetics.
- term:
id: GO:0033499
label: beta-D-galactose catabolic process via UDP-galactose, Leloir pathway
evidence_type: IDA
original_reference_id: PMID:30451973
qualifier: involved_in
review:
summary: >-
Direct-assay (IDA) evidence supporting GALM's participation in the Leloir galactose
catabolic pathway.
action: ACCEPT
reason: >-
Core biological process, directly supported. Duplicate of the IBA/TAS Leloir-pathway
annotations with independent experimental backing.
- term:
id: GO:0004034
label: aldose 1-epimerase activity
evidence_type: IDA
original_reference_id: PMID:12753898
qualifier: enables
review:
summary: >-
Direct assay (IDA) of aldose 1-epimerase activity on purified recombinant human GALM.
action: ACCEPT
reason: >-
Core molecular function; the foundational biochemical characterization of the enzyme.
supported_by:
- reference_id: PMID:12753898
supporting_text: "Enzyme assays show that the protein has aldose 1-epimerase activity and exhibits a preference for galactose over glucose."
- term:
id: GO:0005975
label: carbohydrate metabolic process
evidence_type: IDA
original_reference_id: PMID:12753898
qualifier: acts_upstream_of_or_within
review:
summary: >-
Direct-assay evidence placing GALM in carbohydrate metabolism (mutarotation of hexose
sugars), a high-level grouping process.
action: KEEP_AS_NON_CORE
reason: >-
Correct but very general; the specific galactose/glucose metabolic process terms are more
informative. Retained as a non-core parent. GALM is described as "a key enzyme of
carbohydrate metabolism" (PMID:12753898).
supported_by:
- reference_id: PMID:12753898
supporting_text: "Aldose 1-epimerase or mutarotase (EC 5.1.3.3) is a key enzyme of carbohydrate metabolism catalysing the interconversion of the alpha- and beta-anomers of hexose sugars such as glucose and galactose."
- term:
id: GO:0042803
label: protein homodimerization activity
evidence_type: IDA
original_reference_id: PMID:12753898
qualifier: enables
negated: true
review:
summary: >-
Negated (NOT) annotation: GALM does not have protein homodimerization activity. Biochemical
and structural characterization established that GALM is a monomer.
action: ACCEPT
reason: >-
The NOT annotation correctly records that GALM does not homodimerize. UniProt reports the
SUBUNIT as Monomer (from PMID:12753898 and PMID:15026423). Retaining the negation is
informative and consistent with the monomeric solution and crystal state.
- term:
id: GO:0070062
label: extracellular exosome
evidence_type: HDA
original_reference_id: PMID:19056867
qualifier: located_in
review:
summary: >-
High-throughput mass-spectrometry (HDA) detection of GALM among proteins recovered from
human urinary exosomes.
action: KEEP_AS_NON_CORE
reason: >-
Reflects broad proteomic detection in secreted exosomes rather than the enzyme's site of
catalytic function, which is the cytosol. Kept as a non-core localization; not part of the
core Leloir-pathway function.
supported_by:
- reference_id: PMID:19056867
supporting_text: "we used LC-MS/MS to profile the proteome of human urinary exosomes. Overall, the analysis identified 1132 proteins unambiguously"
- term:
id: GO:0006006
label: glucose metabolic process
evidence_type: IDA
original_reference_id: PMID:12753898
qualifier: involved_in
review:
summary: >-
Direct-assay evidence that GALM mutarotates D-glucose, participating in glucose metabolism.
action: KEEP_AS_NON_CORE
reason: >-
GALM does interconvert glucose anomers, but with lower efficiency than galactose and a
demonstrated preference for galactose (PMID:12753898). A real but secondary activity, not
the core physiological role.
supported_by:
- reference_id: PMID:12753898
supporting_text: "catalysing the interconversion of the alpha- and beta-anomers of hexose sugars such as glucose and galactose"
- term:
id: GO:0006012
label: galactose metabolic process
evidence_type: IDA
original_reference_id: PMID:12753898
qualifier: involved_in
review:
summary: >-
Direct-assay evidence that GALM participates in galactose metabolism via mutarotation of
galactose anomers.
action: ACCEPT
reason: >-
Core biological process; directly demonstrated and consistent with the enzyme's preference
for galactose. Foundational to the Leloir pathway.
supported_by:
- reference_id: PMID:12753898
supporting_text: "catalysing the interconversion of the alpha- and beta-anomers of hexose sugars such as glucose and galactose"
core_functions:
- description: >-
Aldose 1-epimerase (galactose mutarotase) activity: GALM interconverts the beta- and
alpha-anomers of D-galactose in the cytosol, catalyzing the first step of the Leloir pathway
and supplying the alpha-D-galactose required by galactokinase (GALK1).
molecular_function:
id: GO:0004034
label: aldose 1-epimerase activity
directly_involved_in:
- id: GO:0033499
label: galactose catabolic process via UDP-galactose, Leloir pathway
- id: GO:0006012
label: galactose metabolic process
locations:
- id: GO:0005829
label: cytosol
supported_by:
- reference_id: PMID:12753898
supporting_text: "Aldose 1-epimerase or mutarotase (EC 5.1.3.3) is a key enzyme of carbohydrate metabolism catalysing the interconversion of the alpha- and beta-anomers of hexose sugars such as glucose and galactose."
- reference_id: PMID:30451973
supporting_text: "Biallelic GALM pathogenic variants cause a novel type of galactosemia."
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO terms
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000041
title: Gene Ontology annotation based on UniPathway vocabulary mapping
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary
mapping, accompanied by conservative changes to GO terms applied by UniProt
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:12753898
title: Identification and characterisation of human aldose 1-epimerase.
findings:
- statement: >-
Recombinant human GALM has aldose 1-epimerase (mutarotase) activity (EC 5.1.3.3) and
interconverts the alpha- and beta-anomers of hexose sugars, with a preference for galactose
over glucose; site-directed mutagenesis confirmed catalytic/substrate-binding residues.
supporting_text: "Enzyme assays show that the protein has aldose 1-epimerase activity and exhibits a preference for galactose over glucose. Site-directed mutagenesis confirmed the involvement of three residues involved in catalysis and substrate binding."
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Abstract-only in cache (full_text_available: false), but the abstract directly establishes
GALM's core aldose 1-epimerase activity and galactose preference; PMID matches title.
- id: PMID:19056867
title: Large-scale proteomics and phosphoproteomics of urinary exosomes.
findings:
- statement: >-
Large-scale LC-MS/MS proteomics of human urinary exosomes; GALM is among the many proteins
detected in this exosome fraction.
supporting_text: "we used LC-MS/MS to profile the proteome of human urinary exosomes. Overall, the analysis identified 1132 proteins unambiguously"
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
High-throughput proteomics survey supporting only the extracellular-exosome detection
(non-core); does not inform GALM's catalytic function.
- id: PMID:30451973
title: Biallelic GALM pathogenic variants cause a novel type of galactosemia.
findings:
- statement: >-
Biallelic loss-of-function GALM variants impair aldose 1-epimerase activity and the Leloir
pathway, causing a novel (type IV) galactosemia (galactose mutarotase deficiency, GALAC4).
supporting_text: "Biallelic GALM pathogenic variants cause a novel type of galactosemia."
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Abstract-only in cache; establishes the disease relevance (galactosemia type IV) and, via
variant characterization, supports GALM's role in the Leloir galactose catabolic pathway.
- id: Reactome:R-HSA-70370
title: Galactose catabolism
findings: []
- id: Reactome:R-HSA-9931853
title: GALM converts beta-D-GAL to alpha-D-GAL
findings: []
- id: Reactome:R-HSA-9931926
title: Defective GALM doesn't convert beta-D-GAL to alpha-D-GAL
findings: []